.png)
Liver Cancer Diagnostic Market By Screening Type - Global Industry Analysis And Forecast To 2027
Published On : March 2019 Pages : 160 Category: Pharma & Healthcare Report Code : HC032948
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Liver Cancer Diagnostic Market By Screening Type (Biopsy, Laboratory Tests, Endoscopy, Imaging and Other Screening Types) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The liver cancer is the disease that starts in the liver cells. The liver is the organ sized of football that placed in the upper right section of the stomach, underneath the diaphragm or above the stomach. The procedures & tests for the diagnostics are; imaging tests, liver tissue sample, etc. Therefore, the Liver Cancer Diagnostic Market is anticipated to expand and has tremendous scope during the forecast period. The global Liver Cancer Diagnostic Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
By Screening Type the market is segmented into Biopsy, Laboratory Tests, Endoscopy, Imaging and Other Screening Types. The Imaging section is seen to grow the market due to various imaging techniques utilized due to increasing patient count, etc.
Regional Insights
The North American region is leading the global Liver Cancer Diagnostic Market due to development in technology, best coverage for healthcare, more target population seen in this region, faster adoption of the novel treatment, etc.
Liver Cancer Diagnostic Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Illumina Inc.
- Abbott Laboratories
- Koninklijke Philips N.V.
- Roche Diagnostics
- Sirtex Medical ltd.
- Qiagen
- Hologic
- Siemens Healthineers
- Becton, Dickinson and Company
- Thermo Fischer Scientific Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Liver Cancer Diagnostic Market, By Screening Type, Estimates and Forecast, 2017-2027 ($Million)
o Biopsy
o Laboratory Tests
o Endoscopy
o Imaging
o Other Screening Types
o Liver Cancer Diagnostic Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Illumina Inc.
o Abbott Laboratories
o Koninklijke Philips N.V.
o Roche Diagnostics
o Sirtex Medical ltd.
o Qiagen
o Hologic
o Siemens Healthineers
o Becton, Dickinson and Company
o Thermo Fischer Scientific Inc.
o Liver Cancer Diagnostic Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Liver Cancer Diagnostic Market, By Country
o U.S. Liver Cancer Diagnostic Market
o Canada Liver Cancer Diagnostic Market
o Mexico Liver Cancer Diagnostic Market
o Europe
§ Europe Liver Cancer Diagnostic Market, By Country
o Germany Liver Cancer Diagnostic Market
o UK Liver Cancer Diagnostic Market
o France Liver Cancer Diagnostic Market
o Russia Liver Cancer Diagnostic Market
o Italy Liver Cancer Diagnostic Market
o Rest of Europe Liver Cancer Diagnostic Market
o Asia-Pacific
§ Asia-Pacific Liver Cancer Diagnostic Market, By Country
o China Liver Cancer Diagnostic Market
o Japan Liver Cancer Diagnostic Market
o South Korea Liver Cancer Diagnostic Market
o India Liver Cancer Diagnostic Market
o Southeast Asia Liver Cancer Diagnostic Market
o Rest of Asia-Pacific Liver Cancer Diagnostic Market
o South America
§ South America Liver Cancer Diagnostic Market, By Country
o Brazil Liver Cancer Diagnostic Market
o Argentina Liver Cancer Diagnostic Market
o Columbia Liver Cancer Diagnostic Market
o Rest of South America Liver Cancer Diagnostic Market
o Middle East and Africa
§ Middle East and Africa Liver Cancer Diagnostic Market, By Country
o Saudi Arabia Liver Cancer Diagnostic Market
o UAE Liver Cancer Diagnostic Market
o Egypt Liver Cancer Diagnostic Market
o Nigeria Liver Cancer Diagnostic Market
o South Africa Liver Cancer Diagnostic Market
o Rest of MEA Liver Cancer Diagnostic Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Liver Cancer Diagnostic Market, By Screening Type
5.1. Introduction
5.2. Global Liver Cancer Diagnostic Revenue and Market Share by Screening Type (2017-2027)
5.2.1. Global Liver Cancer Diagnostic Revenue and Revenue Share by Screening Type (2017-2027)
5.3. Biopsy
5.3.1. Global Biopsy Revenue and Growth Rate (2017-2027)
5.4. Laboratory Tests
5.4.1. Global Laboratory Tests Revenue and Growth Rate (2017-2027)
5.5. Endoscopy
5.5.1. Global Endoscopy Revenue and Growth Rate (2017-2027)
5.6. Imaging
5.6.1. Global Imaging Revenue and Growth Rate (2017-2027)
5.7. Other Screening Types
5.7.1. Global Other Screening Types Revenue and Growth Rate (2017-2027)
6. Liver Cancer Diagnostic Market, By Region
6.1. Introduction
6.2. Global Liver Cancer Diagnostic Revenue and Market Share by Regions
6.2.1. Global Liver Cancer Diagnostic Revenue by Regions (2017-2027)
6.3. North America Liver Cancer Diagnostic by Countries
6.3.1. North America Liver Cancer Diagnostic Revenue and Growth Rate (2017-2027)
6.3.2. North America Liver Cancer Diagnostic Revenue (Million USD) by Countries (2017-2027)
6.3.3. United States
6.3.3.1. United States Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.4. Canada
6.3.4.1. Canada Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.5. Mexico
6.3.5.1. Mexico Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.4. Europe Liver Cancer Diagnostic by Countries
6.4.1. Europe Liver Cancer Diagnostic Revenue and Growth Rate (2017-2027)
6.4.2. Europe Liver Cancer Diagnostic Revenue (Million USD) by Countries (2017-2027)
6.4.3. Germany
6.4.3.1. Germany Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.4. France
6.4.4.1. France Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.5. UK
6.4.5.1. UK Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.6. Russia
6.4.6.1. Russia Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.7. Italy
6.4.7.1. Italy Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.5. Asia-Pacific Liver Cancer Diagnostic by Countries
6.5.1. Asia-Pacific Liver Cancer Diagnostic Revenue and Growth Rate (2017-2027)
6.5.2. Asia-Pacific Liver Cancer Diagnostic Revenue (Million USD) by Countries (2017-2027)
6.5.3. China
6.5.3.1. China Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.4. Japan
6.5.4.1. Japan Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.5. Korea
6.5.5.1. Korea Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6. India
6.5.6.1. India Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.7. Southeast Asia
6.5.7.1. Southeast Asia Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.8. Rest of Asia-Pacific
6.5.8.1. Rest of Asia-Pacific Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.6. South America Liver Cancer Diagnostic by Countries
6.6.1. South America Liver Cancer Diagnostic Revenue and Growth Rate (2017-2027)
6.6.2. South America Liver Cancer Diagnostic Revenue (Million USD) by Countries (2017-2027)
6.6.3. Brazil
6.6.3.1. Brazil Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.4. Argentina
6.6.4.1. Argentina Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.5. Columbia
6.6.5.1. Columbia Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.6. Rest of South America
6.6.6.1. Rest of South America Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.7. Middle East and Africa Liver Cancer Diagnostic by Countries
6.7.1. Middle East and Africa Liver Cancer Diagnostic Revenue and Growth Rate (2017-2027)
6.7.2. Middle East and Africa Liver Cancer Diagnostic Revenue (Million USD) by Countries (2017-2027)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.4. United Arab Emirates
6.7.4.1. United Arab Emirates Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.5. Egypt
6.7.5.1. Egypt Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.6. Nigeria
6.7.6.1. Nigeria Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.7. South Africa
6.7.7.1. South Africa Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.8. Turkey
6.7.8.1. Turkey Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.9. Rest of Middle East and Africa
6.7.9.1. Rest of Middle East and Africa Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7. Company Profiles
7.1. Illumina Inc.
7.1.1. Business Overview
7.1.2. Service Portfolio
7.1.3. Strategic Developments
7.1.4. Financial Overview
7.2. Abbott Laboratories
7.2.1. Business Overview
7.2.2. Service Portfolio
7.2.3. Strategic Developments
7.2.4. Financial Overview
7.3. Koninklijke Philips N.V.
7.3.1. Business Overview
7.3.2. Service Portfolio
7.3.3. Strategic Developments
7.3.4. Financial Overview
7.4. Roche Diagnostics
7.4.1. Business Overview
7.4.2. Service Portfolio
7.4.3. Strategic Developments
7.4.4. Financial Overview
7.5. Sirtex Medical ltd.
7.5.1. Business Overview
7.5.2. Service Portfolio
7.5.3. Strategic Developments
7.5.4. Financial Overview
7.6. Qiagen
7.6.1. Business Overview
7.6.2. Service Portfolio
7.6.3. Strategic Developments
7.6.4. Financial Overview
7.7. Hologic
7.7.1. Business Overview
7.7.2. Service Portfolio
7.7.3. Strategic Developments
7.7.4. Financial Overview
7.8. Siemens Healthineers
7.8.1. Business Overview
7.8.2. Service Portfolio
7.8.3. Strategic Developments
7.8.4. Financial Overview
7.9. Becton, Dickinson and Company
7.9.1. Business Overview
7.9.2. Service Portfolio
7.9.3. Strategic Developments
7.9.4. Financial Overview
7.10. Thermo Fischer Scientific Inc.
7.10.1. Business Overview
7.10.2. Service Portfolio
7.10.3. Strategic Developments
7.10.4. Financial Overview
8. Global Liver Cancer Diagnostic Market Competition, by Manufacturer
8.1. Global Liver Cancer Diagnostic Revenue and Market Share by Manufacturer (2017-2017)
8.2. Global Liver Cancer Diagnostic Price By Region (2017-2017)
8.3. Top 5 Liver Cancer Diagnostic Manufacturer Market Share
8.4. Market Competition Trend
9. Liver Cancer Diagnostic Market Forecast (2017-2027)
9.1. Global Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Liver Cancer Diagnostic Market Forecast by Regions (2017-2027)
9.2.1. North America Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.1.1. United States Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.1.2. Canada Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.1.3. Mexico Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.2. Europe Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.2.1. Germany Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.2.2. France Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.2.3. UK Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.2.4. Russia Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.2.5. Italy Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.3. Asia-Pacific Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.3.1. China Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.3.2. Japan Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.3.3. Korea Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.3.4. India Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.4. South America Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.4.1. Brazil Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.4.2. Argentina Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.4.3. Columbia Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.4.4. Rest of South America Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.5. Middle East and Africa Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.5.3. Egypt Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.5.4. Nigeria Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.5.5. South Africa Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.5.6. Turkey Liver Cancer Diagnostic Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Liver Cancer Diagnostic Market Forecast (2017-2027)
9.3. Liver Cancer Diagnostic Market Forecast by Screening Type (2017-2027)
9.3.1. Liver Cancer Diagnostic Forecast by Screening Type (2017-2027)
9.3.2. Liver Cancer Diagnostic Market Share Forecast by Screening Type (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Liver Cancer Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Liver Cancer Diagnostic Revenue and Revenue Share by Screening Type (2017-2018)
Figure Global Biopsy Revenue and Growth Rate (2017-2018)
Figure Global Laboratory Tests Revenue and Growth Rate (2017-2018)
Figure Global Endoscopy Revenue and Growth Rate (2017-2018)
Figure Global Imaging Revenue and Growth Rate (2017-2018)
Figure Global Other Screening Types Revenue and Growth Rate (2017-2018)
Table Global Liver Cancer Diagnostic Revenue by Regions (2017-2018)
Figure North America Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure North America Liver Cancer Diagnostic Revenue and Growth Rate (2017-2018)
Figure North America Liver Cancer Diagnostic by Countries (2017-2018)
Figure North America Liver Cancer Diagnostic Revenue (Million USD) by Countries (2017-2018)
Figure United States Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure United States Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Canada Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Mexico Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Europe Liver Cancer Diagnostic Revenue and Growth Rate (2017-2018)
Figure Europe Liver Cancer Diagnostic by Countries (2017-2018)
Figure Europe Liver Cancer Diagnostic Revenue (Million USD) by Countries (2017-2018)
Figure Germany Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Germany Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure France Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure UK Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Russia Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Italy Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Rest of Europe Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Asia-Pacific Liver Cancer Diagnostic Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Liver Cancer Diagnostic by Countries (2017-2018)
Figure Asia-Pacific Liver Cancer Diagnostic Revenue (Million USD) by Countries (2017-2018)
Figure China Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure China Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Japan Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Korea Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure India Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Southeast Asia Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure South America Liver Cancer Diagnostic Revenue and Growth Rate (2017-2018)
Figure South America Liver Cancer Diagnostic by Countries (2017-2018)
Figure South America Liver Cancer Diagnostic Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Brazil Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Argentina Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Columbia Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Rest of South America Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Middle East and Africa Liver Cancer Diagnostic Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Liver Cancer Diagnostic by Countries (2017-2018)
Figure Middle East and Africa Liver Cancer Diagnostic Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Saudi Arabia Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure United Arab Emirates Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Egypt Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Nigeria Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure South Africa Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Turkey Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Liver Cancer Diagnostic Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Table Illumina Inc. Liver Cancer Diagnostic Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories Liver Cancer Diagnostic Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Koninklijke Philips N.V. Liver Cancer Diagnostic Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Roche Diagnostics Liver Cancer Diagnostic Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sirtex Medical ltd. Liver Cancer Diagnostic Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Qiagen Liver Cancer Diagnostic Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Hologic Liver Cancer Diagnostic Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Siemens Healthineers Liver Cancer Diagnostic Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Becton, Dickinson and Company Liver Cancer Diagnostic Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Thermo Fischer Scientific Inc. Liver Cancer Diagnostic Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Liver Cancer Diagnostic Market Share by Manufacturer
Figure Global Liver Cancer Diagnostic Revenue and Market Share by Manufacturer
Table Global Liver Cancer Diagnostic Price by Region (2017-2017)
Figure Top 5 Liver Cancer Diagnostic Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Liver Cancer Diagnostic Revenue (Millions USD) and Growth Rate (2018-2025)
Table Liver Cancer Diagnostic Market Forecast by Regions (2018-2025)
Figure North America Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure United States Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Canada Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Mexico Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Europe Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Germany Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure France Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure UK Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Russia Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Italy Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Rest of Europe Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Asia-Pacific Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure China Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Japan Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Korea Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure India Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Southeast Asia Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure South America Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Brazil Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Argentina Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Columbia Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Rest of South America Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Middle East and Africa Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Saudi Arabia Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure United Arab Emirates Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Egypt Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Nigeria Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure South Africa Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Turkey Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Liver Cancer Diagnostic Market Forecast (2018-2025)
Figure Global Liver Cancer Diagnostic Forecast by Screening Type (2018-2025)
Figure Global Liver Cancer Diagnostic Market Share Forecast by Screening Type (2018-2025)
Figure Global Liver Cancer Diagnostic Forecast by Screening Type (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|